Walgreens Boots Alliance (NASDAQ:WBA) Issues FY25 Earnings Guidance

Walgreens Boots Alliance (NASDAQ:WBA) updated its FY25 earnings guidance on Friday. The company provided earnings per share (EPS) guidance of $1.40-$1.80 for the period, compared to the consensus estimate of $1.52. Walgreens Boots Alliance also updated its FY 2025 guidance to 1.400-1.800 EPS.

Walgreens Boots Alliance Stock Performance

WBA opened at $9.22 on Friday. Walgreens Boots Alliance has a 1-year low of $8.08 and a 1-year high of $25.63. The company has a market capitalization of $7.96 billion, a price-to-earnings ratio of -0.92, a price-to-earnings-growth ratio of 1.36 and a beta of 0.64. The business has a 50 day moving average price of $9.21 and a two-hundred day moving average price of $9.92. The company has a debt-to-equity ratio of 0.67, a current ratio of 0.68 and a quick ratio of 0.37.

Walgreens Boots Alliance (NASDAQ:WBA) last announced its earnings results on Friday, January 10th. The pharmacy operator reported $0.51 earnings per share for the quarter, beating the consensus estimate of $0.38 by $0.13. Walgreens Boots Alliance had a positive return on equity of 14.23% and a negative net margin of 5.85%. The business had revenue of $39.50 billion during the quarter, compared to analysts’ expectations of $37.40 billion. During the same quarter last year, the business posted $0.66 earnings per share. The company’s quarterly revenue was up 7.6% on a year-over-year basis. Research analysts predict that Walgreens Boots Alliance will post 1.53 EPS for the current fiscal year.

Walgreens Boots Alliance Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Thursday, December 12th. Investors of record on Monday, November 18th were paid a dividend of $0.25 per share. This represents a $1.00 annualized dividend and a yield of 10.85%. The ex-dividend date of this dividend was Monday, November 18th. Walgreens Boots Alliance’s dividend payout ratio is presently -9.99%.

Analysts Set New Price Targets

WBA has been the subject of a number of recent research reports. Royal Bank of Canada cut their price objective on Walgreens Boots Alliance from $13.00 to $9.00 and set a “sector perform” rating for the company in a research report on Wednesday, December 4th. Morgan Stanley dropped their price target on Walgreens Boots Alliance from $9.00 to $7.00 and set an “underweight” rating on the stock in a research note on Friday, October 11th. Jefferies Financial Group decreased their target price on shares of Walgreens Boots Alliance from $19.00 to $9.00 and set a “hold” rating for the company in a report on Wednesday, October 23rd. Barclays boosted their price target on shares of Walgreens Boots Alliance from $7.00 to $8.00 and gave the company an “underweight” rating in a report on Wednesday, October 16th. Finally, Evercore ISI raised their price objective on shares of Walgreens Boots Alliance from $7.50 to $10.00 and gave the stock an “in-line” rating in a research note on Wednesday, October 16th. Four analysts have rated the stock with a sell rating, nine have issued a hold rating and two have assigned a buy rating to the stock. Based on data from MarketBeat, the company presently has a consensus rating of “Hold” and an average price target of $12.58.

About Walgreens Boots Alliance

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.